Specifically, the TGF-β1–SMAD3 signaling pathway has been highlighted in AD murine models to influence the production of systemic IgE and promote allergen-induced skin inflammation (Anthoni et al., 2007). The gene discussed is SMAD3; the disease is Alzheimer disease.